Table 4.
Week 42 | Tibia strength | BMDa | Medullary area | Serum Cab | CTc | PTHd | cOCe | ucOCf | cOC/(cOC + ucOC) |
---|---|---|---|---|---|---|---|---|---|
Tibia strength | 1.00 | ||||||||
BMDa | −0.43 | 1.00 | |||||||
medullary area | 0.11 | −0.52 | 1.00 | ||||||
Serum Cab | −0.63 | 0.39 | −0.19 | 1.00 | |||||
CTc | −0.72 | 0.66 | −0.51 | 0.94 | 1.00 | ||||
PTHd | −0.35 | 0.75 | −0.58 | 0.82 | 0.89 | 1.00 | |||
cOCe | −0.40 | 0.55 | −0.52 | 0.93 | 0.99* | 0.94 | 1.00 | ||
ucOCf | −0.42 | 0.58 | −0.38 | 0.93 | 0.93 | 0.96* | 0.96* | 1.00 | |
cOC/(cOC + ucOC) | 0.38 | −0.78 | 0.61 | −0.82 | − 0.90 | −1.00* | −0.95* | − 0.96* | 1.00 |
aBMD Bone mineral density
bSerum Ca Serum calcium
cCT Calcitonin
dPTH Parathyroid hormone
ecOC Carboxylated osteocalcin
fucOC Undercarboxylated osteocalcin
*Correlation is significant at P < 0.05
Note: The correlation is based on the 6 samples, n = 6/treatment, the tibia parameters were the average values of both sides